Eighty-eight-year-old Sharon Beck, retired teacher and metastatic breast cancer patient, participated in a clinical trial for an investigational oral selective estrogen receptor degrader (SERD) and found success. Clinical trials provide access to leading-edge treatments, but older patients rarely choose to participate due to various factors. However, Sharon was willing to participate in a clinical trial. Her doctor, Dhatri Kodali, was amazed at her willingness to participate in the clinical trial and her incredible support system in her family. Sharon emphasizes the importance of research in cancer and clinical trials and would do it again if the opportunity presented itself.
“It made sense that we were going to have to do something a little out of the ordinary since it’d spread throughout my body, but I was willing to do anything“
Sharon Beck
Breast Cancer